Thrombin receptor overexpression in malignant and physiological invasion processes

Nature Medicine

Volumn 4, Issue 8, 1998, Pages 909-914

  Even Ram, Sharona ^a   Uziely, Beatrice ^a   Cohen, Patrizia ^a   Grisaru Granovsky, Sorina ^b   Maoz, Miriam ^a   Ginzburg, Yoav ^a   Reich, Reuven ^a   Vlodavsky, Israel ^a   Bar Shavit, Rachel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; THROMBIN RECEPTOR;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CYTOTROPHOBLAST; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; TISSUE SPECIFICITY; TUMOR GROWTH;

ADENOCARCINOMA; BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CELL LINE; DNA, ANTISENSE; DNA, COMPLEMENTARY; EMBRYO IMPLANTATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLACENTA; PREGNANCY; RECEPTORS, THROMBIN; RECOMBINANT PROTEINS; TRANSFECTION; TROPHOBLASTS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031927754     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0898-909     Document Type: Article

References (44)

1. Redman, C.W.G. Cytotrophoblast: Markers of disguise. Nature Med. 3, 610-611 (1997).
2. Zetter, B.R. The cellular basis of site-specific tumor metastasis. N. Engl. J. Med. 322, 605-612 (1990).
3. Rusciano, D. & Burger, M.M. Why do cancer cells metastasize into particular organs? Bioessays 14, 185-194 (1992).
4. Liotta, L., Rao, CN. & Wewer, U.M. Biochemical interaction of tumor cells with the basement membrane. Ann. Rev. Biochem. 55, 1037-1057 (1986).
5. Lester, B.R. & McCarthy, J.B. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion, and metastasis. Cancer Metastasis, Rev. 11, 31-44 (1992).
6. Ruoslahti, E. Control of cell motility and tumor invasion by extracellular matrix interactions. Br. J. Cancer 66, 239-242 (1992).
7. 3 rescues melanoma cells from apoptosis in three dimensional dermal collagen. Proc. Natl. Acad. Sci. USA 91, 8856-8860 (1994).
8. Blasi, F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasion. Bioessays 15, 105-111 (1993).
9. Vu, T-K., Hung, H.D.T., Wheaton V.I. & Coughlin, S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068 (1991).
10. +2 mobilization. FEBS Lett. 288, 123-128 (1991).
11. Gerszten, R.E. et al. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 368, 648-649 (1994).
12. Nystedt, S., Emilsson, K., Wahlestedt, C. & Sundelin, J. Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. USA 91, 9208-9212 (1994).
13. Nystedt, S., Emilsson, K., Larsson, A-K., Strombeck, B. & Sundelin, J. Molecular cloning and functional expression of the gene coding for the human proteinase-activated receptor 2. Eur. J. Biochem. 232, 84-89 (1995).
14. Ishihara, H. et al. Protease-activated receptor-3 is a second thrombin receptor in humans. Nature 386, 502-506 (1997).
15. Strickland, S. & Richards, W.G. Invasion of trophoblasts. Cell 71, 355-357 (1992).
16. Cross, J.C., Werb, Z. & Fisher, S.Z. Implantation and the placenta: Key pieces of the development puzzle. Science 266, 1508-1518 (1994).
17. Damsky, H.C., Fitzgerald, M.L. & Fisher, S.J. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J. Clin Invest. 89, 210-222 (1992).
18. Harris, J.R. Placental endogenous retrovitus (ERV): Structural, functional and evolutionary significance. BioEssay 20, 307-316 (1998).
19. Page, D.L. et al. Atypical hyperplastic lesions of the female breast: a long term follow-up study. Cancer 55, 2698-2708 (1985).
20. Page, D.L., Steel, C.M. & Dixon, J.M. Carcinoma in situ and patient at high risk of breast cancer. Br. Med. J. 310, 39-42 (1995).
21. Silverstein, M.J. et al. Duct Carcinoma in situ: 227 cases without micro invasion. Eur. J. Cancer 28, 630-634 (1992).
22. Fisher, B. et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N. Engl. J. Med. 328, 1581-1586 (1993).
23. Page, D.L. et al. Continued local recurrence of carcinoma in situ 15-25 years after biopsy only for low grade ductal carcinoma in situ of the breast. Cancer 76, 1197-1200 (1995).
24. Albini, A. et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239-3245 (1987).
25. Lee, K.S. et al. Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin. Exp. Metastasis 14, 512-519 (1996).
26. Kim, S.Y. et al. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression. Breast Cancer Res. Treat. 43, 175-181 (1997).
27. Walz, D.A. & Fenton II, J.W. The role of thrombin in tumor metastasis. Invasion Metastasis 14, 303-308 (1994).
28. Nehls, V. & Herrmann, R. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc. Res. 51, 347-364 (1996).
29. Esumi, N., Fan, D. & Fidler, I. J. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res. 51, 4549-4556 (1991).
30. Wojtukiewicz, M.Z. et al. Thrombin increases the metastatic potential of tumor cells. Int. J. Cancer 54, 793-806 (1993).
31. Wojtukiewicz, M.Z. et al. Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha II b beta 3 expression on the cell surface. Thromb. Res. 68, 233-245 (1992).
32. Wojtukiewicz, M.Z. et al. Solid tumor cells express functional "tethered ligand" thrombin receptor. Cancer Res 55, 698-707 (1995).
33. Pyke, C.E., Ralkiaer, E., Tryggvson, K. & Dano, K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol 142, 359-365 (1993)
34. Pyke, C. et al. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol. 138, 1059-1067 (1991).
35. Sivaraman, V.S., Wang, H-Y., Nuovo, G.J. & Malbon, C.C. Hyperexpression of Mitogen-activated Protein Kinase in Human Breast Cancer. J. Clin. Invest. 99, 1478-1483 (1977).
36. Chen, Y.H. et al. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the C protein-coupled thrombin-receptor. EMBO J. 15, 1037-1044 (1996).
37. Duhamel-Clerin, E. et al. Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17, 1931-1938 (1997).
38. Fernandez, P.L. et al. Immunohistochemical profile of basement membrane proteins and 72 kilodalton type IV collagenase in the implantation placental site. Lab. Invest. 66, 572-579 (1992).
39. Shimonovitz, S. et al. Developmental regulation of the expression of 72 and 92 kd of type IV collagenases in human trophoblasts: A possible mechanism for control of trophoblast invasion. Am. J. Obstet. Gynecol. 171, 832-838 (1994).
40. 1 fibronectin receptor supresses transformed phenotype of Chinese hamster ovary cells. Cell 60, 849-859 (1990).
41. Soule, H.D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6086 (1990).
42. Miller, F.R. et al. Xenograft model of progressive human proliferative breast disease. J. Natl. Cancer Inst. 85, 1725-1732 (1993).
43. Feinberg, V. & Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem 132, 6-13 (1984).
44. Saiki, R.K. et al. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 239, 489-491 (1981).